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SUMMARY.-The indirect immunofluorescence technique demonstrated that
human alpha fetoprotein (AFP) was present in a focal pattern in the cytoplasm
of malignant liver cells ofpatients whose sera contained AFP. Afew fibroblast-
like cells in tissue culture of liver biopsies from patients with hepato-cellular
carcinoma and AFP in their sera also had the protein. The intracellular
localisation of human AFP was confirmed by centrifugation of washed, homo-
genised and ultra-sonically disrupted neonatal liver cells. Examination of
livers of fetuses and neonates showed that AFP was present predominantly
in the periportal parenchymal cells.
ALPHA fetoprotein (AFP) is known to be secreted by the fetal liver of mice,
rats and man (Abelev and Bakirov, 1967; Luria et al., 1969; Van Furth and Adin-
olfi, 1969). It is produced by transplantable mouse hepatoma (Irlin et al., 1966).
Tatarinov (1965a) demonstrated the appearance of AFP in the serum of some
patients with primary liver cell carcinoma and teratocarcinoma. Using the agar
double diffusion technique, less than 50% of hepatocellular carcinomas in Europe
and between 70 and 80% in some parts of Africa were shown to produce serum
AFP (Foli et al., 1969; Sankale et al., 1970). Why some hepatomas secrete AFP
and others do not is unknown. In this study, an attempt has been made to
localise the site of production of AFP by immunofluorescence and at the subeel-
lular level by centrifugation. The sensitivities of the immunofluorescent and the
Ouchterlony techniques have also been compared.
MATERIALS AND METHODS
Liver.-Portions of liver from a 28 weeks aborted fetus, a 5 hours autopsied
neonate, eight necropsied patients five of whom had AFP in their sera, were
fixed in 10% formalin for conventional histology. Other portions from each
source were snap-frozen in liquid nitrogen and stored at -70° C. These tissues
were obtained within 48 hours of death and stored for up to 1 week in some cases
before use.
Antiserum.-Rabbit antiserum to human AFP was obtained by the method
of Masopust et al. (1968). It was made monospecific according to the method of
Abelev et al. (1967). The total globulin from 10 ml. of the monospecific rabbit
antiserum was precipitated with 10 ml. of saturated (NH4)2SO4. The precipitate
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was dissolved in 4 ml. phosphate buffered saline (PBS) at pH 7-5 and dialysed
against the PBS for 24 hours at 40 C. The solution was afterwards concentrated
to 2 ml. by ultrafiltration at 40 C. It was absorbed for 20 minutes at 40 C. with
human liver powder prepared according to the method of Holborow and Johnson
(1967).
Immunofiuorescence.-Cryostat sections were cut at 4 Ia. They were dried with
a hair drier. Two drops of absorbed rabbit antiserum were layered on the section
and allowed to react at room temperature (RT) for 30 minutes in a moist chamber.
The antiserum was washed off with PBS for 30 minutes under magnetic stirring.
It was changed once. Two drops of fluorescein conjugated swine anti-rabbit
globulin (Conjugate made by Institute of Sera and Vaccines, Praha, Czechoslo-
vakia) previously absorbed with guinea-pig and human liver powders were then
put on the sections for 30 minutes. The conjugate was also put on control slides
to which antiserum had not been added. The conjugate had previously been
tested by double diffusion for monospecificity to the rabbit antiserum. It gave
only one precipitin line. The slides were again washed with PBS for 30 minutes
with one change halfway through. Ten per cent glycerine was used as mountant.
The preparations were examined with a fluorescent microscope using HBO 200
mercury vapour lamp as source, BG 12 primary and 490 m,u secondary filters.
Serial cryostat sections of the liver stained for immunofluorescent studies were
also stained with H. and E. and Giemsa respectively. Comparison of sections
from each liver studied was made to correlate areas ofpositive specific fluorescence
with the same areas as seen on conventional histology. Also after the immuno-
fluorescent examination, the same tissue culture slides and cryostat sections were
again stained with Giemsa.
Tissue culture.-Human liver cells were cultured by a modification of the
methods of Zuckerman et al. (1967); Zuckerman (1967); Sullman et al. (1968) and
Taylor et al. (1969). Tissues were obtained either from open surgical or closed
needle biopsies. They were cut into several minute pieces and initially trypsi-
nised with 0.25% trypsin for 30 minutes before culturing in ring chambers on
chicken plasma clot. It was later found unnecessary to trypsinise or to use plasma
clot. Culture medium consisted of TC 199, 20% human serum, 1% chicken
embryo extract, neomycin 33 units/ml., and mycostatin 125 units/ml. Incubation
was at 370 C. Carbon dioxide atmosphere was not used. After various intervals
ranging from 18 to 141 days fibroblast-like cells, which could not be subcultured
(Zuckerman, 1970, personal communication), were harvested. The harvested
slides and coverslips were washed with PBS for 2 hours and dried overnight at
RT (25° C.). The same procedure of indirect immunofluorescent staining as
described above was applied. The complete medium and its individual compon-
ents were tested against rabbit antiserum by double diffusion in agar. No
precipitin lines were produced even after ten fold concentration.
The origin of the liver biopsies cultured were from patients with diseases
shown in Table I. At the time of examination the cells had been in culture for
varying periods as shown also in Table I.
Homogenisation.-Fragments of 20 g. fetal liver were cut into small pieces
and washed with PBS until free of visible blood. The pieces of tissue were
homogenised with 5 ml. PBS in a hand glass homogeniser. Part of the homo-
genate was centrifuged at 750 g and RT for 5 minutes. Three zones were obtained.
The upper two were greyish and the deposit red. The first two zones were pooledFETOPROTEIN IN HEPATOCELLULAR CARCINOMA CELLS
TABLE I.-Summary of Data on Tissue Culture Cellsfrom 13 Liver
Biopsies
Sex Duration IMF
Number of Age in of culture test for
Diagnosis patients M F years in days AFP
(1) AFP positive hepatoma 4 3 1 24-50 19, 26, ++
50, 50 + +
(2) AFP negative hepatoma 1 1 - 45 141
(3) Hepatic metastasis of
gastric carcinoma 2 1 1 . 45, 65 18, 82
(4) Chronic duodenal ulcer 2 2 - 24, 30 109
(5) Post necrotic cirrhosis of
the liver . 1 1 - . 35 26
(6) Chronic active hepatitis . I - . 40 . 66
(7)Kwashiorkor 1 6 41
(8) Secondary biliary cirrhosis . 1 1 - . 3/12 . 67
together and labelled supernatant I. The two samples were examined with the
phase contrast microscope. Supernatant I was centrifuged at 800 g and 40 C.
for 30 minutes. Two zones were again obtained, a supernatant and a deposit.
An equal volume of PBS was added to the deposit and centrifuged at 800 g and
40 C. for 30 minutes. This procedure was continued until the supernatant, after
ten-fold concentration by ultrafiltration, no longer reacted with rabbit antiserum
to AFP by double diffusion. The deposit of cells was then disrupted by ultra-
sonication and centrifuged according to the method of Williams and McFarlane
(1968). The zones obtained were concentrated a ten fold by ultrafiltration and
tested for AFP by double diffusion.
RESULTS
Immunoftuorescence
(a) Cryostat sections.-In the fetal and neonatal liver most of the immuno-
fluorescence was periportal in localisation. All the hepatocytes of the limiting
plate, one or two cells thick, around the portal tract showed fluorescence. Only
occasional hepatocytes showed fluorescence in other parts of the liver lobule.
The fluorescence in each positive cell was homogeneous and limited to the cyto-
plasm (Fig. 1). In the liver of AFP seropositive hepatocellular carcinoma,
fluorescence was patchy in distribution. It was present either in single cells or
in a clump of cells usually not more than five in a neoplastic area. In a low
power field (x 70 magnification) the total number of fluorescent cells was never
more than 20% of all the cells seen in the field. The fluorescence was also homo-
geneous and cytoplasmic as in fetal cells. There was no fluorescence in any
hepatocyte from AFP negative hepatocellular carcinomas or the livers of those
that died of other diseases (Fig. 2). Furthermore there was no fluorescence in
the non-malignant hepatocytes ofthe AFP positive primary liver cell carcinomas.
Sometimes fluorescence along the sinusoids focally in both the controls and hepa-
toma patients was seen (Fig. 2). Some cytoplasmic granular orange auto-
fluorescent spots were sometimes seen in the cytoplasm of the non-malignant
hepatocytes (Fig. 2).
(b) Tissue culture.-There was marked fluorescence of the extracellular
granular debris which presumably was not removed by washing. There was
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cytoplasmic staining of a few fibroblast-like cells only in AFP positive hepato-
cellular carcinoma cultures but the numbers were very few, only one or sometimes
none being seen per low power field (Fig. 3). At least one positive cell was seen
in each of the four AFP positive liver cell carcinoma cultures. No cytoplasmic
fluorescence was seen in any of the other cultures although some staining of the
cell margins was noted especially in two cultures. The only AFP negative
hepatoma, which had also been in culture for the longest period did not show
fluorescence. It was not possible to say whether the number of cells showing
fluorescence decreased, increased or remained static with time. However, one
of the more recent cultures from a positive hepatoma showed a few clumps of
fluorescent cells in contrast to the single cells seen in all the others.
Morphologically all the cells were fibroblast-like (Fig. 4). Cultures from the
malignant tumours showed greater variation in cell size with slightly more mitotic
figures. The large sometimes multinucleated brownish granular cells seen with
the phase contrast microscope in the first few weeks of culture could not be
identified by immunofluorescence. They were seen after staining with Giemsa
in some of the slides.
The supernatants from the culture chambers of these cells, collected over
various intervals during feeding and before this experiment, were tested with-
out concentration by the double diffusion technique. No precipitin lines were
seen in any. Further studies on the concentrated supernatants are presently in
progress.
Homogenate of neonatal liver
The homogenate and supernatant I gave precipitin lines with rabbit antiserum
to human AFP. Phase contrast microscopy of supernatant I showed many intact
cells, free nuclei and organelles that appeared as granules. On centrifuging at
800 g and 40 C. for 30 minutes, the cells were sedimented and the supernatant
clear. On sonication and centrifugation at 800 g and 40 C. for 30 minutes, three
zones were obtained: namely-a clear supernatant with organelles and cell
membrane fragments, a middle white nuclear zone and a deposit of a few intact
cells and debris. Ten-fold concentration of the three zones and testing of each
gave aprecipitinline onlywiththesupernatant. A similar experiment ona control
liverfrom an adult patient who died in a road accident failed to give anyprecipitin
line.
EXPLANATION OF PLATES
FIG. 1.-Post mortem liver section from a 5-hour-old male neonate that was delivered after
40 weeks gestation. There is diffuse homogenous cytoplasmic fluorescence predominantly
of the periportal hepatocytes, for AFP. x 100. Indirect immunofluorescent technique.
FIG. 2.-Post-mortem liver section from a 45-year-old man with AFP seronegative hepato-
cellular carcinoma in a non-cirrhotic liver. Cytoplasmic fluorescence is absent except in
focal areas due to autofluorescent granules. Occasional parasinusoidal fluorescence is
present. Indirect immunofluorescent technique. x 100.
FIG. 3.-19 days tissue culture cells from needle liver biopsy of 24-year-old man with AFP
seropositive hepatocellular carcinoma. One fibroblast-like cell shows diffuse cytoplasmic
fluorescence. Indirect immunofluorescent technique. x 450.
FIG. 4.-26 days tissue culture cells from needle liver biopsy of a 36-year-old woman with
AFP seropositive hepatocellular carcinoma. Morphologically the cells are spindle-shaped
(fibroblast-like). May-Grunwald-Giemsa stain. x 180.BRIISH JOURNAL OF CANCER.
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DISCUSSION
It has been demonstrated that liver cells synthesize AFP. Irlin et al. (1966)
used tissue culture cells of transplantable ascitic hepatoma and double diffusion.
Abelev and Bakirov (1967) demonstrated AFP with the aid of immunoauto-
radiography in the livers of newly born mice and rats and Luria et al. (1969) with
organ culture of embryonal mouse liver. Van Furth and Adinolfi (1969) used
human fetal livers in vitro by double diffusion and immunoautoradiography.
The indirect immunofluorescent technique confirmed these findings in this study.
The distribution of the cells that contain AFP and its intracellular localisation
has not been commented on, as far as we know. The presence ofAFP in the fetal,
neonatal and some hepatoma livers only in focal hepatocytes was an unexpected
observation. It had been presumed that all the liver cells would secrete AFP.
That only about 20% of the hepatocytes secrete AFP in the 28 weeks fetus seems
to justify the suggestion of Tatarinov (1965b) and Sankale et al. (1970) that there
are two specific types of liver cells. There are those that are intrinsically capable
of producing AFP and others that are not, in the same liver. If in neoplasia
AFP positiveliver cell carcinomas originate from cells imbued with the capacity to
produce AFP, it would be expected that all the malignant hepatocytes in an AFP
positive patient would have AFP. This was contrary to our observation. It
thus appears that putative AFP positive and negative cells become malignant
concurrently or that the intrinsic AFP positive cells can give rise to both AFP
positive and negative hepatocytes during neoplasia. If in the fetus and neonate
there are thus primary AFP positive and primary AFP negative hepatocytes,
it is postulated that the AFP positive fetal hepatocytes either die out or are trans-
formed to secondary AFP negative hepatocytes in the adult. During neoplasia
in the fetus or neonate the primary AFP positive hepatocyte may give rise to
AFP positive or negative hepatoma. In the adult the primary AFP negative
cells give rise to only AFP negative liver cell carcinoma whilst the secondary AFP
negative cells may be retransformed to AFP positive hepatocellular carcinoma or
may remain as AFP negative ones. If with maturation all AFP positive cells
die out, some AFP negative hepatocytes must transform to produce AFP in neo-
plasia. However if all hepatocytes are originally primarily AFP positive, then
all AFP negative cells are only secondarily so.
During malignant transformation there is loss of normal lobular architecture.
It is not surprising therefore that the periportal distribution of AFP containing
hepatocytes seen in the fetus and neonate is absent in the carcinomatous liver.
However, it is possible that in AFP secreting liver cell carcinomas the first neoplas-
tic group of cells are those derived from the periportal areas. Whether all the
hepatocytes ofthe fetus and hepatomas produce AFP but do so at different rates
or in different zones of the lobules at different times is not elucidated by this
study.
Theparticular subcellular organelle where AFP is produced might be elucidated
by differential ultracentrifugation. Some proteins have been shown to be
synthesised in the rough endoplasmic reticulum of the cytoplasm (Loewy and
Siekevitz, 1966). Others are associated with mitochondria (Perlman andPenman,
1970). Generally, globulins are synthesised by cells of the reticuloendothelial
system (Popper and Schaffner, 1957; Hadziyannis et al., 1969). It is therefore
also interesting to find AFP, whose molecular weight is close to that ofalbumin,
being synthesised in liver cells per se and not in the reticular cells of the liver.
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Because of the transient nature of AFP, its site of production at the subcellular
level may differ from that of the more persistent proteins. Our experiments only
confirm the intracellular presence of AFP.
Gitlin and Boesman (1967) and Van Furth and Adinolfi (1969) observed that
AFP is at its maximum concentration in the fetus of 20 weeks gestation. Several
possibilities could account for this. There may be more cells producing AFP at
this time with gradual depletion of these specific cells as the fetus grows. It
may be that the metabolic activity of the fetus is maximum as this period. The
larger size of the fetus as it grows older may cause a relative dilution of
AFP.
Irlin et al. (1966) observed that during the early stages of cultivation of mouse
transplantable ascitic hepatoma, AFP, albumin and B 2-1 globulin were demon-
strated in the tissue culture medium for up to 13 weeks. In the course of subse-
quent cultivation, the production of AFP ceased in 16 weeks while albumin and
B 2-1 globulin were present in the medium during the whole period of cultivation
which was up to 69 weeks. In our experiments human AFP was detectable in the
cultured cells by immunofluorescence 50 days after primary cultivation. The
rate of catabolism of AFP is unknown. It is possible that some of the AFP
detected may be the remnant in the originally explanted cells rather than AFP
that is freshly synthesized. Work is in progress to find out how long AFP secretion
can persist in vitro. Irlin et al. (1966) also found that transplantation of some
mouse ascitic hepatoma that had stopped secreting AFP in vitro into a new set
of mice reactivated its synthesis in vivo.
Although Gitlin and Boesman (1967) and Van Furth and Adinolfi (1969)
showed that AFP is not produced by other fetal tissues apart from the liver, a
confirmation of their findings by the immunofluorescent technique is warranted.
This was not done during this study.
The indirect immunofluorescent technique is as sensitive as the double diffusion
method for the detection ofAFP. Whether it is more sensitive is difficult to say
from this study because ofthe small numbers involved. However, from the small
percentage of AFP secreting cells, a false negative result could be obtained by
sampling error especially from needle biopsy specimens.
It is well known that serum proteins can leak passively into cells after cell
death (Kent, 1969). Most of this work was done on autopsy material and this
could be said to account for the fluorescence seen. The striking distribution of
specific fluorescence in the fetal and neonatal liver, the presence of fluorescent
hepatocytes in two liver biopsies from live AFP positive hepatoma patients, and
the presence of AFP in tissue culture cells from similar patients strongly suggest
that the AFP detected was synthesised by the cells.
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